CurcumaSorb provides the patented Meriva® curcumin-phosphatidylcholine complex for enhanced absorption and bioavailability. The proprietary phytosome technology combines curcumin and phosphatidylcholine at a 1:2 ratio promoting resistance to degradation in the digestive tract and efficient absorption across membranes. This produces significantly higher peak plasma concentrations and larger area under concentration-time curves (AUC). In a single-dose pharmacokinetic animal study, plasma curcumin levels were 20-fold greater with Meriva® than standard curcumin. A preliminary human pharmacokinetic study demonstrated that elevations in plasma curcumin from 450 mg Meriva® were similar to values obtained from 4,000 mg of a standard curcumin extract. The efficacy of a low dose was demonstrated in a 3-month clinical trial, in which 200 mg curcuminoids from Meriva® per day maintained healthy C-reactive protein levels and provided significant benefit in joint comfort, mobility and quality of life.
CurcumaSorb delivers highly bioavailable curcumin, providing maximal support for musculoskeletal, digestive, liver, brain, cellular and cardiovascular health.
Amount per serving:
one vegetarian capsule contains:
Meriva® turmeric phytosome250 mg.
- (Curcuma longa extract (root) and phospholipid complex)
other ingredients: hypoallergenic plant fiber (cellulose), vegetarian capsule (cellulose, water)
2–6 capsules per day, in divided doses, between meals.
- (standardized to contain 18% curcuminoids)